Tolmar is committed to the development, approval, and commercialization of specialty pharmaceutical products dedicated to advancing patient care in urology. We are focused on the needs of today, with a vision of tomorrow that drives our dedication to the urology community and the patients it serves.
ELIGARD’s innovative in-situ polymeric gel extended delivery system provides controlled drug release enabling consistent suppression of testicular testosterone synthesis throughout the dosing period.
Downloads
Eligard Clinical Summary — PDF
Prescribing Information — PDF